Trial Details

TERMINATED
Basic Information
Clinical ID c3302
Identifier NCT02255227
Trial Title Anti-pneumococcal Vaccine Strategy in Patients Treated With Immunosuppressants or Biotherapies for CIBD
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Infections, Pneumococcal|Bowel Diseases, Inflammatory
Interventions BIOLOGICAL: Prevenar 13|BIOLOGICAL: Pneumo 23
Participant Information
Sponsor Centre Hospitalier Universitaire de Saint Etienne
City Amiens
Country/Region France
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE2
Time Information
Start Date 2015-04-13
Primary Completion Date 2019-08-06
Completion Date 2022-07-06